Hemostasis Today

July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Dhruvi Joshi: Reduced-Dose DOAC Therapy in Patients With Venous Thromboembolism
May 25, 2026, 13:04

Dhruvi Joshi: Reduced-Dose DOAC Therapy in Patients With Venous Thromboembolism

Dhruvi Joshi, Founder and Creator at The 25th Hour Project, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in JSCAI, adding:

“Thrilled to share our meta-analysis, now published in the Journal of the Society for Cardiovascular Angiography and Interventions (JSCAI)!

Across 5 RCTs involving 8,781 patients with VTE, reduced-dose DOACs demonstrated a significant reduction in major bleeding (1.2% vs 2.0%; RR 0.62; p=0.019) and clinically relevant non-major bleeding (5.2% vs 7.0%; RR 0.75; p<0.001), with no significant difference in recurrent VTE (RR 0.92) or all-cause mortality (RR 0.86) compared to full-dose regimens.

Results were consistent across patients with and without active cancer.

My sincerest gratitude to Dr. Saraschandra Vallabhajosyula, for his invaluable mentorship and guidance through every step of the way.

Beyond grateful to Dr. Zeeshan Mansuri, Siddharth Pravin Agrawal, Hritvik Jain, Zaraith Coy Neira, Mir wajid Majeed and Caroline Serafim Dagostin for their support.”

Title: Reduced-Dose vs Full-Dose Direct Oral Anticoagulants for Extended Anticoagulation Therapy in Patients With Venous Thromboembolism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Authors: Dhruvi K. Joshi, Najwaa Kirmani, Zaraith Coy, Siddharth P. Agrawal, Mir W. Majeed, Caroline Dagostin, Hritvik Jain, Zeeshan Mansuri, Peter A. Soukas, J. Dawn Abbott, Saraschandra Vallabhajosyula

Dhruvi Joshi: Reduced-Dose DOAC Therapy in Patients With Venous Thromboembolism

Stay updated on all scientific advances with Hemostasis Today.